AustraliaTuberculosis profile
Population  2014 24 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.042 (0.042–0.042) 0.18 (0.18–0.18)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.02 (0.01–0.03)
Prevalence  (includes HIV+TB) 1.9 (0.81–3.5) 8.1 (3.4–15)
Incidence  (includes HIV+TB) 1.5 (1.3–1.7) 6.4 (5.6–7.2)
Incidence (HIV+TB only) 0.026 (0.023–0.03) 0.11 (0.1–0.13)
         
Case detection, all forms (%) 88 (78–100)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 1.7 (0.86–3) 10 (2.8–24)
MDR-TB cases among notified pulmonary
TB cases
14 (7–24) 6 (2–13)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 721   42
Pulmonary, clinically diagnosed 78   1
Extrapulmonary 474   14
       
Total new and relapse 1 330    
Previously treated, excluding relapses 13    
Total cases notified 1 343    
Among 1 330 new and relapse cases:
53 (4%) cases aged under 15 years; male:female ratio: 1.1
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 954 (132%) 55 (79%) 1 017
Laboratory-confirmed RR-/MDR-TB cases     24
Patients started on MDR-TB treatment ***     23
TB/HIV 2014 Number (%)
TB patients with known HIV status 1 069 (80)
HIV-positive TB patients 17 (2)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (85) 1 264
Previously treated cases, excluding relapse, registered in 2013 (83) 6
HIV-positive TB cases, all types, registered in 2013 (77) 26
RR-/MDR-TB cases started on second-line treatment in 2012 (75) 16
XDR-TB cases started on second-line treatment in 2012   0
Laboratories 2014  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2015  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-09-30 Data: www.who.int/tb/data